Mattsson A, Ögren SO, Olson L (2000) 192 IgG-saporin immunolesioning causes marked facilitation of dopamine-mediated locomotor activity in adult rats. Neuroscience 2000 Abstracts 563.7. Society for Neuroscience, New Orleans, LA.
Summary: Recent studies have indicated a possible link between changes in cholinergic mechanisms and schizophrenia. However there is limited information regarding the functional consequences of changes in ACh transmission on DA functions, which in turn are believed to be involved in schizophrenic symptoms. 192 IgG-saporin targets cells that express the low-affinity p75 neurotrophin receptor. Intracerebroventricular injection causes severe lesions of the cholinergic projections and may also damage Purkinje neurons. We have compared intracerebroventricular injections of 192 IgG SAP to adult rats (5 μg) with injections to neonate rats (0.4 μg day 4 or 0.4 μg day 4 + 0.8 μg day 13). As expected, treated adult rats are markedly impaired in the Morris swim maze both in terms of time to find the platform and in search behavior when the platform is removed, i.e. memory impairment. When tested as adults, neonatally treated animals were only modestly impaired. Interestingly, adult treated animals showed increased spontaneous motility and locomotion and markedly increased locomotor responses to amphetamine (1.5 mg/kg) as evidenced by increased rearing, motility and locomotion. These animals also responded to apomorphine (1 mg/kg) with an increased amount of rearing. There were no marked changes of locomotor activity in rats treated with 192 IgG SAP at 4 days or 4 and 13 days of age. Our results suggest that cholinergic denervation of the forebrain causes a marked enhancement of the behavior responses related to increased dopaminergic activity. However, it cannot be fully excluded that damage to non-cholinergic systems, e.g. Purkinje cells, might contribute to the effects. The striking overreaction to dopaminergic stimuli presumably caused by the cholinergic deficit is possibly relevant in relation to the role of cholinergic malfunctioning in schizophrenia.
Related Products: 192-IgG-SAP (Cat. #IT-01)